Myasthenia gravis management

Evoli A, Batocchi AP, and Tonali P. A practical guide to the recognition and management of myasthenia gravis. Drugs 1996 52 662-670. 

Pyridostigmine [peer id doe STIG meen] is another cholinesterase inhibitor that is used in the chronic management of myasthenia gravis. Its duration of action (3-6 hours) is longer than that of neostigmine (2-4 hours). 

A fine tremor occurred when isoflurane was used in the management of a 3-year-old boy with pneumonia and underlying congenital myasthenia gravis (8). 

In addition, several autoimmune reactions to penicillamine can secondarily affect pulmonary function. PeniciUamine-induced polymyositis (56) or myasthenia gravis can cause respiratory failure, even requiring ventilatory support (57). The diagnosis and management of lupus-induced pleurisy have been reviewed (58). 

---